Status:
TERMINATED
A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A study to determine the safety and efficacy of an investigational drug in patients with obesity plus extension.
Eligibility Criteria
Inclusion
- Obese patients with a body mass index between 30 kg/m2 and 43 kg/m2, inclusive (BMI between 27 kg/m2 and 43 kg/m2, inclusive for those with obesity-related comorbidities including hypertension, dyslipidemia, and sleep apnea
Exclusion
- Patients with serious or unstable current or past medical conditions
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT00131404
Start Date
September 1 2005
End Date
December 1 2008
Last Update
February 5 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.